XML 59 R46.htm IDEA: XBRL DOCUMENT v3.19.1
Earnings Per Share and Stock Plans (Tables)
12 Months Ended
Mar. 31, 2019
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of basic and diluted earnings per share (share data presented in thousands):
 
 
 
Year Ended March 31,
Numerator for basic and diluted earnings per share:
 
2019
 
2018
 
2017
Net income
 
$
42,577

 
$
22,065

 
$
8,984

 
 
 
 
 
 
 
Denominators:
 
 

 
 

 
 

Weighted-average common stock outstanding— denominator for basic EPS
 
23,276

 
22,841

 
20,591

Effect of dilutive employee stock options, RSU's and performance shares
 
384

 
494

 
297

 
 
 
 
 
 
 
Adjusted weighted-average common stock outstanding and assumed conversions— denominator for diluted EPS
 
23,660

 
23,335

 
20,888

Schedule of Stock Options Roll Forward
A summary of option transactions during each of the three fiscal years in the period ended March 31, 2019 is as follows:
 
 
Shares
 
Weighted-
average
Exercise Price per share
 
Weighted-
average
Remaining
Contractual
Life (in years)
 
Aggregate
Intrinsic
Value
Outstanding at April 1, 2016
 
718,801

 
20.13

 
6.64
 
$
465

Granted
 
398,945

 
17.00

 
 
 
 
Exercised
 
(27,848
)
 
15.76

 
 
 
 
Cancelled
 
(26,004
)
 
19.06

 
 
 
 
Outstanding at March 31, 2017
 
1,063,894

 
19.10

 
6.98
 
$
6,477

Granted
 
227,783

 
24.33

 
 
 
 
Exercised
 
(363,091
)
 
17.43

 
 
 
 
Cancelled
 
(6,136
)
 
19.83

 
 
 
 
Outstanding at March 31, 2018
 
922,450

 
21.04

 
7.56
 
$
13,654

Granted
 
133,743

 
38.70

 
 
 
 
Exercised
 
(187,907
)
 
22.09

 
 
 
 
Cancelled
 
(33,509
)
 
23.94

 
 
 
 
Outstanding at March 31, 2019
 
834,777

 
23.52

 
7.04
 
$
9,602

Exercisable at March 31, 2019
 
342,921

 
$
20.71

 
5.74
 
$
4,686

Schedule of Share-based Compensation, Stock Options, Activity
The following table provides certain information with respect to stock options outstanding at March 31, 2019:

 
 
Stock Options
Outstanding
 
Weighted-average
Exercise Price
 
Weighted-average
Remaining
Contractual Life
Range of Exercise Prices
 
 
 
 
 
 
$10.01 to 20.00
 
317,938

 
$
15.56

 
5.88
$20.01 to 30.00
 
388,814

 
25.02

 
7.33
$30.01 to $40.00
 
128,025

 
38.70

 
9.04
 
 
834,777

 
$
23.52

 
7.04

The following table provides certain information with respect to stock options exercisable at March 31, 2019:

Range of Exercise Prices
 
Stock Options
Exercisable
 
Weighted- average
Exercise Price per share
$10.01 to $20.00
 
172,842

 
$
15.90

$20.01 to $30.00
 
168,578

 
25.47

$30.01 to $40.00
 
1,501

 
38.70

 
 
342,921

 
$
20.71

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The following table provides the weighted-average assumptions used to value stock options granted during fiscal 2019, 2018, and 2017:

 
 
Year Ended
March 31,
2019
 
Year Ended
March 31,
2018
 
Year Ended
March 31,
2017
Assumptions:
 
 
 
 
 
 
Risk-free interest rate
 
2.64
%
 
1.42
%
 
1.07
%
Dividend yield
 
0.52
%
 
0.66
%
 
0.98
%
Volatility factor
 
0.352

 
0.343

 
0.379

Expected life
 
5.5 years

 
5.5 years

 
5.5 years

Schedule of Unvested Restricted Stock Units Roll Forward
A summary of the restricted stock unit awards granted under the Company’s LTIP plan as of March 31, 2019 is as follows:

 
 
Shares
 
Weighted-average
Grant Date
Fair Value per share
Unvested at April 1, 2016
 
371,502

 
$
20.26

Granted
 
171,407

 
18.06

Vested
 
(162,502
)
 
19.93

Forfeited
 
(10,151
)
 
22.81

Unvested at March 31, 2017
 
370,256

 
$
19.32

Granted
 
136,935

 
29.38

Vested
 
(157,448
)
 
20.39

Forfeited
 
(12,954
)
 
17.99

Unvested at March 31, 2018
 
336,789

 
$
22.62

Granted
 
116,942

 
37.90

Vested
 
(211,932
)
 
22.66

Forfeited
 
(11,602
)
 
25.18

Unvested at March 31, 2019
 
230,197

 
$
30.22

Schedule of Nonvested Performance-based Units Activity
A summary of the performance shares transactions during each of the three fiscal years in the period ended March 31, 2019 is as follows:

 
 
Shares
 
Weighted-average
Grant Date
Fair Value per share
Unvested at April 1, 2016
 
101,653

 
$
26.15

Granted
 
77,349

 
15.69

Vested
 
(25,148
)
 
26.79

Forfeited
 
(35,001
)
 
27.12

Unvested at March 31, 2017
 
118,853

 
$
18.92

Granted
 
49,221

 
25.28

Forfeited
 
(41,504
)
 
24.94

Unvested at March 31, 2018
 
126,570

 
$
19.42

Granted
 
34,695

 
36.43

Forfeited
 
(7,879
)
 
22.40

Unvested at March 31, 2019
 
153,386

 
$
23.11